Merkel cell carcinoma (MCC) is a rare, potentially aggressive primary cutaneous neuroendocrine carcinoma. MCC commonly occurs on sun-exposed skin in fair-skinned elderly individuals. It usually presents as a banal-appearing lesion, and the diagnosis is rarely suspected at the time of biopsy. We describe the cytomorphologic, histopathological, and immunohistochemical characteristics of MCC in a 76-year-old male patient presenting with rapidly evolving large red raised lesion over cheek for 1 month. Cytohistopathological evaluation suggested MCC. Immunohistochemistry revealed that the tumor cells were negative for leukocyte common antigen, S-100 protein, HMB45, and cytokeratin 20 and positive for neuron specific enolase. Because of the documented aggressiveness and rising incidence, early diagnosis of this rare tumor is necessary for the management of MCC. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
iNtroductioN This is a rare tumor of the elderly presenting mainly in Caucasians (0.23 annual age adjusted incidence per 100,000) with a high concentration of primary tumors on sun-exposed sites. [1] Merkel cell carcinoma (MCC) has a nonspecific clinical presentation although rapid growth of a firm, red to violaceous, nontender papule, or nodule is often noted. The majority of patients present with clinically localized disease. However, the disease can rapidly spread to regional and distant sites. Diagnosis is made through biopsy, almost invariably with the aid of immunohistochemistry (IHC), classically demonstrating a perinuclear dot pattern of cytokeratin-20 staining. [2] We describe the cytological, histological, and IHC features of MCC.
caSe report
A 76-year-old male presented with a red raised lesion over the left cheek with involvement of the same side eyelid, rapidly progressing to the present size of 6 cm × 5 cm × 6 cm over 1 month. The swelling was covered over by black adherent crust. Surrounding skin was erythematous and edematous [ Figure 1 ]. There was no associated itching or pain and bled on trivial trauma. There were no systemic complaints. Contrast-enhanced computerized tomography paranasal sinus and nose showed heterogeneously enhancing mass in subcutaneous plane of the left cheek, maxillary prominence, nasofacial groove with wide spread extension posteriorly to maxillary sinus, bony erosion, and cervical lymphadenopathy. Clinically, possibility of keratoacanthoma, squamous cell carcinoma, and basal cell carcinoma (BCC) were suggested. 
diScuSSioN
MCC often presents as a rapidly growing, asymptomatic, reddish-blue dermal papule or nodule that develops over the course of weeks to months; the primary lesion of MCC is distinguished by its absence of distinctive clinical characteristics. Rarely suspected at the time of biopsy, the clinical differential diagnosis includes more common lesions such as BCC, epidermoid cyst, or even amelanotic melanoma. [3] It primarily affects the sun-exposed areas of the skin, with approximately 50% of all tumors occurring in the face and neck, 40% appear on the extremities, and 10% on the trunk and genitals. Rare occurrences in sun-protected areas have been described. The tumor spreads frequently; common secondary sites include the skin (28%), lymph nodes (27%), liver (13%), lung (10%), bones (10%), and brain (6%). [4] Many primary and metastatic tumors may resemble MCC. FNA cytology of MCC is usually cellular and composed of small-to medium-sized cells in a predominantly single-cell pattern. The nuclei are uniform, round to oval, with delicate nuclear membranes and finely granular chromatin pattern. The cytoplasm is scanty. Rosette formation is very rare. Frequent mitotic figures and individual cell necrosis are frequently noted. [5] On histopathology, MCC arises in the dermis and frequently extends into the subcutaneous fat. The tumor is composed of small blue cells with hyperchromatic nuclei and minimal cytoplasm. Mitoses are frequently abundant, and apoptosis is often widespread. Lymphovascular invasion is an almost invariable feature. [4] The major differential diagnosis includes metastatic oat cell carcinoma, metastatic carcinoids, malignant lymphomas, and occasionally, other tumors such as melanomas composed of small cancer cells, and very remotely, BCC that may be composed of cells of similar sizes. Except for BCC that forms cohesive clusters of cells, all other tumors show dispersed cancer cells. [6] Immunohistochemical demonstration of neuron-specific enolase, intense staining for keratins (CK7 and CK20), and absence of S100 protein, leukocyte common antigen, and HMB45 are enough to confirm the diagnosis. Cytokeratin 20 presents dot-like and crescent patterns. Occasional cases of MCC are negative for CK20. [7] It has been reported that CK20 is expressed in 87% of MCCs [8] as also seen in our case. Thyroid transcription factor-1 may help with the differential diagnosis from metastatic small cell carcinoma because no reactivity has been shown in MCC. [7] Our case underlines that caution should be taken in excluding the diagnosis of MCC only on the basis of the absence of immunoreactivity for CK20, favoring the wrong diagnosis of less aggressive skin tumors and panel of antibodies be used in differential diagnosis in morphologically similar skin tumor.
The National Comprehensive Cancer Network 2010 guidelines for the management of MCC recommended excision of the primary tumor whenever possible. Complete local lymph nodal dissection is recommended for sentinel lymph-node biopsy (SLNB) positive or palpable-nodal disease. Adjuvant radiation therapy to the excised tumor bed and draining lymph node basin regardless of SLNB results is suggested as a means of minimizing regional recurrence. Radiation alone is also listed as an acceptable alternative to surgery when excision is not feasible or is refused by the patient. Chemotherapy with or without surgery and radiation therapy is reserved for Stage IV disease and is generally palliative. [9] Figure 6: Tumor cells had pleomorphic round to irregular nuclei, conspicuous 1-3 macronucleoli, moderate amount of eosinophilic to vacuolated cytoplasm. Atypical mitotic figure is also seen (H and E, ×100) 
coNcLuSioN
MCC is an aggressive cutaneous malignancy whose clinical diagnosis is seldom made at the time of clinical presentation. The incidence of MCC is on the rise, and increasing awareness along with advances in immunohistopathologic staining has greatly aided in diagnosis. The IHC profile of our case underlines that caution should be taken in excluding the diagnosis of MCC only on the basis of the absence of immunoreactivity for CK20 and that a panel of antibody should be used in differential diagnosis of morphologically similar skin tumors.
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